Freshpaint, a company dedicated to making websites HIPAA compliant through its Privacy Platform, has successfully raised $30 million in funding. The company is on a mission to revolutionize data infrastructure by prioritizing patient privacy while also empowering marketing teams to promote access to healthcare. This substantial funding will enable Freshpaint to further develop its innovative platform, expand its reach, and continue to lead the way in ensuring secure and compliant digital experiences for healthcare organizations and their patients. The company's commitment to bridging the gap between privacy and marketing is evident in their cutting-edge technology, and this recent funding will undoubtedly propel Freshpaint to new heights in the industry.
Freshpaint Secures $30 Million in Series B Funding to Drive HIPAA Compliance and Healthcare Access
Recently funded 路 $30.0M Series bTechnology/Marketing
Get the full Freshpaint company profile
Access contacts, investors, buying signals & more
Other recently funded companies
View all
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
$1.5M Pre-seed
today
Dognosis
Dognosis is a deep-tech startup in Bangalore decoding canine cognition to reveal the hidden world of scent. Our vision is a world where we have cracked the olfactory code of disease, making detecting disease as easy as breathing. Our mission is to save lives by detecting disease early and advance humanity towards truly proactive and preventative medicine. Our work revolves around increasing the bandwidth of human-canine collaboration, allowing us to catch the scent of disease at scale. Our first goal is to solve for early cancer detection by pioneering a multi-cancer breath-based test - BreathEasy - that will be ultra-affordable, highly accurate, and super accessible. We're always on the lookout for passionate and ambitious people to work with us. Feel free to say hi to woof@dognosis.tech
Other recent Series b rounds
Companies that recently closed a Series b round.
| # | Company | Round | Amount | Date |
|---|---|---|---|---|
| 1 |  NEW ID | Series b | $705.2K | today |
| 2 |  Arist United States | Series b | $14.1M | today |
| 3 |
